| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | APTO | Common Shares | Sale | $51,590 | -15,400 | -38% | $3.35 | 24,600 | 21 Jun 2021 | Direct | F1, F2 |
| transaction | APTO | Common Shares | Sale | $31,104 | -9,600 | -39% | $3.24 | 15,000 | 22 Jun 2021 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Converted from Canadian sale price of C$4.146 using an exchange rate of C$1.2377 = US$1.00. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from C$4.12 to C$4.16, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. |
| F3 | Converted from Canadian sale price of C$4.002 using an exchange rate of C$1.2356 = US$1.00. |
| F4 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from C$3.99 to C$4.12, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above |